JSPRW
Japer Therapeutics Warrants (JSPRW)
$
21About Japer Therapeutics Warrants (JSPRW)
Jasper Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in enabling cures through hematopoietic stem cell therapy. It focuses on the development and commercialization of safer, stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation. The company was founded by Judith Shizuru and Susan Prohaska in March 2018 and is headquartered in Redwood City, CA.
Details
Daily high
$0.21
Daily low
$0.19
Price at open
$0.19
52 Week High
$0.38
52 Week Low
$0.04
Market cap
--
Dividend yield
0.00%
Volume
232
Avg. volume
4,370
P/E ratio
--
Japer Therapeutics Warrants News
Details
Daily high
$0.21
Daily low
$0.19
Price at open
$0.19
52 Week High
$0.38
52 Week Low
$0.04
Market cap
--
Dividend yield
0.00%
Volume
232
Avg. volume
4,370
P/E ratio
--